InvestLog
CTNM logo

CTNM

Contineum Therapeutics, Inc. Class A Common StockNASDAQHealthcare
$13.44+0.00%ClosedMarket Cap: $501.8M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-06Baird—Outperform—
2026-01-08Morgan Stanley—Equal Weight—
2025-11-24Baird—Outperform—
2025-11-21RBC Capital—Outperform—
2025-08-18Morgan Stanley—Overweight—
2025-05-19Morgan Stanley—Overweight—
2025-05-15RBC Capital—Outperform—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-2.18$3.7M4
Sun Dec 31$-2.27$3.4M3
Mon Dec 31$-2.44$21.8M2
Tue Dec 31$-3.03$25.4M2